Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia

This is a small phase I study examining the safety and efficacy of a cladribine (CLAD)-containing conditioning regimen prior to autologous hematopoietic stem cell transplantion (auto-HSCT) for patients with acute myeloid leukemia (AML). All patients, aged 15–54 years (median 32 years), had favorable...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuan-Yuan, Liu, Zeng-Yan, Zhang, Gui-Xin, He, Yi, Han, Ming-Zhe, Feng, Si-Zhou, Zhang, Rong-Li, Jiang, Er-Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936063/
https://www.ncbi.nlm.nih.gov/pubmed/36817152
http://dx.doi.org/10.3389/fphar.2023.1014306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936063/
https://www.ncbi.nlm.nih.gov/pubmed/36817152
http://dx.doi.org/10.3389/fphar.2023.1014306

Ejemplares similares